Sun Pharma looking to divest Ireland plant

Last Updated: Thursday, September 10, 2015, 08:04

"Decisions are being made to either close or divest some of our manufacturing facilities," a Sun Pharma spokesman said in an emailed statement.

Jefferies maintains buy call on Sun Pharma despite adverse guidance

Last Updated: Tuesday, July 21, 2015, 19:11

International brokerage house Jefferies said it is positive about Sun Pharma's strong key fundamentals, though its stock plunged 15 percent Tuesday, a day after the company warned of a deeper cut in bottomline and topline this year due to ongoing integration with Ranbaxy.

Sun Pharma shares crash 15%; m-cap dips by Rs 34,055 crore

Last Updated: Tuesday, July 21, 2015, 19:10

Shares of Sun Pharma plunged 15 percent Tuesday, wiping out Rs 34,055.55 crore from its market valuation, after the drug major said it expects to take a hit on profit for the fiscal due to charges related to the ongoing integration with Ranbaxy Laboratories.

Complaint against Sun Pharma for anti-trust violations in US

Last Updated: Friday, May 15, 2015, 17:42

Ranbaxy Laboratories, recently acquired by Sunpharma, has been sued in the US District Court in Massachusetts for allegedly manipulating USFDA rules.

Sun Pharma, not sated by Ranbaxy deal, may spend up to $7 billion on M&A: Bankers

Last Updated: Tuesday, April 28, 2015, 11:13

Sun Pharma, which has a market value of nearly $36 billion, is also interested in non-biotech complex generic medicine.

Sun Pharma shares bounce back, up 3% on bourses

Last Updated: Wednesday, April 22, 2015, 13:09

Stocks of Sun Pharmaceutical made a comeback at the bourses Wednesday, rising nearly 3 percent, a day after Japanese drugmaker Daiichi Sankyo sold its entire stake of around 9 per cent in the company for Rs 20,025 crore.

Ranbaxy stock to stop trading on exchanges from next week

Last Updated: Saturday, April 4, 2015, 23:15

Shares of Ranbaxy Laboratories will stop trading on BSE and NSE with effect from April 6 onwards as the company is merging with Sun Pharmaceutical Industries in a USD 4 billion deal.

Ranbaxy ends last trading day on bright note; surges over 5%

Last Updated: Wednesday, April 1, 2015, 19:07

Shares of Ranbaxy Laboratories on Wednesday ended with strong gains on the last day of its trade, as the company is being merged with Sun Pharmaceutical in a USD 4 billion deal.

Sun Pharma to delist Ranbaxy on completion of $4 bn merger

Last Updated: Wednesday, March 25, 2015, 14:06

The merger has fortified Sun Pharma's position as the world's fifth largest speciality generic pharmaceutical firm.

Sun Pharma gets RBI nod for transfer of Ranbaxy overseas investments

Last Updated: Tuesday, March 24, 2015, 13:55

The central bank also approved issue of equity shares of Sun Pharma to the non-resident holders of equity shares of Ranbaxy Laboratories, the filing added.

Ranbaxy merger: Sun Pharma readies new leadership team

Last Updated: Thursday, March 12, 2015, 15:10

Taking forward its acquisition of Ranbaxy Laboratories, Sun Pharma has put in place a team of top executives, including Dilip Shanghvi's son Aalok Shanghvi, to lead the businesses of both the organisations.

HC allows merger of Ranbaxy and Sun pharma

Last Updated: Monday, March 9, 2015, 23:00

The Punjab and Haryana High Court Monday gave its nod to the merger of two Indian pharmaceutical companies - Ranbaxy Laboratories Limited with Sun Pharmaceutical Industries Limited.